HKU Scholars Hub: Browsing DSpace

Browsing by Author Yung, MH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 20 of 30 next >

Title	Author(s)	Issue Date	Views
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade Journal:BMC Cancer	Yung, MH Chan, DW Liu, VWS Yao, KM Ngan, HYS	2013	69
AMP-activated protein kinase gamma-2 (AMPK-g2) subunit modulates AMPK activities to ensure ovarian cancer progression Proceeding/Conference:International Symposium on AMP-activated Protein Kinase, AMPK 2016	Chan, DW Yung, MH Hardie, DG Ngan, HYS	2016	106
AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling Activity Journal:PLoS ONE	Kwan, HT Chan, DW Cai, C Mak, SL Yung, MH Leung, THY Wong, GW Cheung, ANY Ngan, HYS	2013	109
The AMPK/TAK1 signaling axis is indispensable for controlling ovarian cancer cell metabolism and omental metastasis Proceeding/Conference:CSHAsia 2013 Conference on Metabolism, Obesity & Obesity-associated Diseases	Chan, DW Cai, C Yung, MH Ngan, HYS	2013	87
Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance Journal:Oncogene	Zhou, W Sun, W Yung, MH Dai, S Cai, Y Chen, CW Meng, Y Lee, JB Braisted, JC Xu, Y Southall, NT Shinn, P Huang, X Song, Z Chen, X Kai, Y Cai, X Li, Z Hao, Q Cheung, ANY Ngan, HYS Liu, S Barak, S Hao, J Dai, Z Tzatsos, A Peng, W Pei, H Han, Z Chan, DW Zheng, W Zhu, W	2018	130
BCL2A1 plays a biphasic role in ovarian cancer progression: promoting cell survival and inhibiting cell proliferation Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism	Liang, R Yung, MH Ngan, HYS Chan, DW	2016	56
Bitter melon (Momordica charantia) extract functions as a natural AMPK activator and synergistically enhances cisplatin cytotoxicity in ovarian cancer cells Journal:Integrative Cancer Therapies	YUNG, MH ROSS, FA HARDIE, DG ZHAN, JB Ngan, HYS Chan, DW	2016	17
Bitter melon (Momordica charantia) extract inhibits tumorigenicity and overcomes cisplatin-resistance in ovarian cancer cells through targeting AMPK signaling cascade Proceeding/Conference:HKU O & G 90th Anniversary Celebration-Symposium	Yung, MH Leung, THY Ngan, HYS Chan, DW	2015	79
Bitter melon extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth Proceeding/Conference:CSH Asia / ICMS 2012 Joint Conference on Tumor Microenvironment	Yung, MH Chan, DW Ngan, HYS	2012	30
Bitter Melon Extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth Proceeding/Conference:Research Postgraduate Symposium, RPS 2012	Yung, MH Chan, DW Ngan, HYS	2012	30
Bitter Melon Extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012	Yung, MH Chan, DW Ngan, HYS	2012	26
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling Journal:Oncogene	Chan, DW Hui, WW Wang, JJ Yung, MH Hui, MN Qin, YIMING LIANG, R Leung, THY Xu, D Chan, KKL Yao, KM Tsang, BK Ngan, HYS	2016	131
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer Journal:Cancer Letters	Meng, Y Chen, CW Yung, MH Sun, W Sun, J Li, Z Li, J Li, Z Zhou, W Liu, S Cheung, ANY Ngan, HYS Braisted, JC Kai, Y Peng, W Tzatsos, A Li, Y Dai, Z Zheng, W Chan, DW Zhu, W	2018	114
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis Journal:Cancers	WANG, X Yung, MH Sharma, R Chen, F Poon, YT Lam, WY Li, B Ngan, HYS Chan, KKL Chan, DW	2021
ERK regulates HIF1α-mediated platinum resistance by directly targeting PHD2 in ovarian cancer Journal:Clinical Cancer Research	Li, Z Zhou, W Zhang, Y Sun, W Yung, MH Sun, J Li, J Chen, CW Li, Z Meng, Y Chai, J Zhou, Y Liu, S Cheung, ANY Ngan, HYS Chan, DW Zheng, W Zhu, W	2019	91
Functional characterization of MAP30 protein from bitter melon (Momordica charantia) in combating ovarian cancer oncogenesis and chemoresistance Proceeding/Conference:International Symposium on AMP-activated Protein Kinase, AMPK 2016	Yung, MH Ngan, HYS Hardie, DG Chan, DW	2016
GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade Proceeding/Conference:Cold Spring Harbour Asia Conference on Inflammation: Basic Mechanisms & Relevant Diseases	Chan, DW Chen, R Yung, MH Ngan, HYS	2017
GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade Journal:Theranostics	Yung, MH Tang, WM Cai, CH Leung, THY Ngu, SF Chan, KKL Xu, D Yang, H Ngan, HYS Chan, DW	2018	96
Identification of MAP30 as a natural AMPK activator in targeting the tumorigenicity and chemoresistance of ovarian cancer cells Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism	Yung, MH Ngan, HYS Chan, DW	2016	82
MAP30 protein of momordica charantia functions as a natural AMPK activator in combating tumorigenic and chemoresistant capacities of ovarian cancer Proceeding/Conference:Croucher ASI 2013 on Tumour Microenvironment - Cancer Cell Metabolism	Chan, DW Yung, MH Ngan, HYS	2013	28

Showing results 1 to 20 of 30 next >